E C Ren|S H Chan - JoVE Visualize

Showing results (451-460 of 475) with videos related to

Pageof 48

Sort By:

IARC Scientific Publications|January 1, 1978

Nasopharyngeal carcinoma and histocompatibility antigensM J Simons, S H Chan, G B Wee, et al.

Oral Oncology|February 18, 2014

The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRTWai Tong Ng, Michael C H Lee, Amy T Y Chang, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2014

Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy eraAnne W M Lee, Wai Tong Ng, Lucy L K Chan, et al.

Head & Neck|November 30, 2016

Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinomaOscar S H Chan, Henry C K Sze, Michael C H Lee, et al.

Oral Oncology|September 28, 2014

Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?Henry Sze, Lucy L K Chan, W T Ng, et al.

Journal of Medicinal Chemistry|July 9, 2019

Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based ApproachesAndrew J Whitehouse, Sherine E Thomas, Karen P Brown, et al.

Anticancer Research|July 1, 1997

Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinomaP I Hsu, N H Chow, K H Lai, et al.

Nature|April 29, 2011

Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'Helen S Goodridge, Christopher N Reyes, Courtney A Becker, et al.

Frontiers in Oncology|June 13, 2022

Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor AntibodiesAnissa S H Chan, Takashi O Kangas, Xiaohong Qiu, et al.

Lung Cancer (Amsterdam, Netherlands)|February 24, 2020

ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKIOscar S H Chan, Kwok Chi Lam, Jacky Y C Li, et al.

Pageof 48

Showing results (451-460 of 475) with videos related to

Sort By:

Pageof 48

IARC Scientific Publications|January 1, 1978

Nasopharyngeal carcinoma and histocompatibility antigensM J Simons, S H Chan, G B Wee, et al.

Oral Oncology|February 18, 2014

The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRTWai Tong Ng, Michael C H Lee, Amy T Y Chang, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2014

Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy eraAnne W M Lee, Wai Tong Ng, Lucy L K Chan, et al.

Head & Neck|November 30, 2016

Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinomaOscar S H Chan, Henry C K Sze, Michael C H Lee, et al.

Oral Oncology|September 28, 2014

Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?Henry Sze, Lucy L K Chan, W T Ng, et al.

Journal of Medicinal Chemistry|July 9, 2019

Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based ApproachesAndrew J Whitehouse, Sherine E Thomas, Karen P Brown, et al.

Anticancer Research|July 1, 1997

Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinomaP I Hsu, N H Chow, K H Lai, et al.

Nature|April 29, 2011

Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'Helen S Goodridge, Christopher N Reyes, Courtney A Becker, et al.

Frontiers in Oncology|June 13, 2022

Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor AntibodiesAnissa S H Chan, Takashi O Kangas, Xiaohong Qiu, et al.

Lung Cancer (Amsterdam, Netherlands)|February 24, 2020

ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKIOscar S H Chan, Kwok Chi Lam, Jacky Y C Li, et al.

Pageof 48